Affiliation:
1. Department of Applied Biotechnology and Food Science, Budapest University of Technology and Economics, 1111 Budapest, Hungary
2. CycloLab Cyclodextrin R & D Laboratory Ltd., 1097 Budapest, Hungary
Abstract
Cyclodextrins, commonly used as excipients in antifungal formulations to improve the physicochemical properties and availability of the host molecules, have not been systematically studied for their effects and bioactivity without a complex active substance. This paper evaluates the effects of various cyclodextrins on the physiology of the test organism Candida boidinii. The research examines their impact on yeast growth, viability, biofilm formation and morphological changes. Native ACD, BCD, randomly methylated α- and β-CD and quaternary ammonium α-CD and β-CD were investigated in the 0.5–12.5 mM concentration range in both static and dynamic systems. The study revealed that certain cyclodextrins exhibited notable antifungal effects (up to ~69%) in dynamic systems; however, the biofilm formation was enhanced in static systems. The magnitude of these effects was influenced by several variables, including the size of the internal cavity, the concentration and structure of the cyclodextrins, and the contact time. Furthermore, the study found that CDs exhibited distinct effects in both static and dynamic systems, potentially related to their tendency to form aggregates. The findings suggest that cyclodextrins may have the potential to act as antifungal agents or growth promoters, depending on their structure and surrounding environments.
Funder
Richter Gedeon Excellence Ph.D. Scholarship of Richter Gedeon Talentum Foundation
Ministry of Culture and Innovation of Hungary from the Hungarian National Research, Development and Innovation Fund
Reference39 articles.
1. Walker, G.M., and Stewart, G.G. (2016). Saccharomyces cerevisiae in the Production of Fermented Beverages. Beverages, 2.
2. The life and times of yeasts in traditional food fermentations;Tofalo;Crit. Rev. Food Sci. Nutr.,2020
3. Emerging opportunistic yeast infections;Miceli;Lancet Infect. Dis.,2011
4. Nosocomial fungal infections: Epidemiology, diagnosis, and treatment;Perlroth;Med. Mycol.,2007
5. Soe, H.M.S.H., Maw, P.D., Loftsson, T., and Jansook, P. (2022). A Current Overview of Cyclodextrin-Based Nanocarriers for Enhanced Antifungal Delivery. Pharmaceuticals, 15.